Skip to content
Stop using now Drug recall · FDA · Published October 8, 2026

Eagle Pharma Recalls Phenylephrine Infusion Due to Sterility Risk

Eagle Pharma recalls 50 containers of Phenylephrine HCL Infusion due to lack of sterility assurance. Check lot PHENYL100-1004.

🇺🇸 FDA recall #D-0105-2027DrugEagle Pharma ›
✎ GovInfoNow plain-language explainer

What happened, in plain English

Eagle Pharma Outsourcing LLC is recalling a specific lot of Phenylephrine HCL Infusion because there is no assurance that the product remains sterile. The recall affects 50 containers distributed nationwide within the U.S. This issue poses a potential infection risk to patients receiving this medication. Read more at govinfonow.com/recall/2084742-eagle-pharma-outsourcing-llc-recalls-phenylephrine-hcl-infusion-100-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/2084742-eagle-pharma-outsourcing-llc-recalls-phenylephrine-hcl-infusion-100-mg · Updated November 11, 2026 · FDA enforcement record: FDA #D-0105-2027

Cite this page

“Eagle Pharma Recalls Phenylephrine Infusion Due to Sterility Risk.” GovInfoNow, updated November 11, 2026. https://govinfonow.com/recall/2084742-eagle-pharma-outsourcing-llc-recalls-phenylephrine-hcl-infusion-100-mg. Based on FDA recall #D-0105-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0105-2027%22&limit=1).

Why it’s dangerous

The product lacks assurance of sterility, meaning harmful microorganisms could be present in the solution. Using a non-sterile intravenous infusion can lead to serious infections or sepsis in patients.

Who’s affected

Healthcare providers and patients in the United States who received the specific lot of Phenylephrine HCL Infusion from Eagle Pharma Outsourcing LLC are affected. Patients relying on this sterile infusion for medical treatment are at risk of infection.

How to tell if you have this one

Check if you have Phenylephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use. Look for NDC 69852-100-25, Lot PHENYL100-1004, and Expiry date 12/31/2026. The UPC is 6985210025.

  • Brand
    Eagle Pharma
  • Product
    PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    Nationwide within the U.S
Recall numberProduct, codes & lotsQuantity
D-0105-2027PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25; Lot: PHENYL100-1004, Expiry: 12/31/2026.50 250 mL-containers
D-0106-2027OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50; Lot: OXY30-1006, Expiry: 10/10/2026.5 500-mL containers
Based on the official FDA remedy

What to do — step by step

  1. Stop Using the Product

    Do not administer or use any Phenylephrine HCL Infusion from the recalled lot due to sterility concerns.

  2. Identify Affected Lots

    Verify if your inventory matches Lot PHENYL100-1004, NDC 69852-100-25, and Expiry 12/31/2026.

  3. Contact Manufacturer

    Reach out to Eagle Pharma Outsourcing LLC for further instructions on handling the recalled product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the U.S” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 27 days after the firm started it.

1. Firm started the recall: Oct 8, 202612. FDA classified it Class II: Oct 28, 202623. Published in FDA’s Enforcement Report: Nov 4, 202634. Added to GovInfoNow: Nov 10, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0105-2027 (October 8, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0105-2027 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on November 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA